 This study is a three-armed, randomized, patient, physician, and assessor-blinded, controlled pilot to the aim of evaluating the comparative clinical effectiveness of pharmacopuncture for severe non-acute sciatic pain patients diagnosed with lumbar disc herniation LDH with usual care of conventional medicine and that of Korean medicine acupuncture. Sixty patients with severe non-acute sciatic pain patients diagnosed with LDH NRS 5, onset between 4 weeks and 6 months will be recruited, and randomized 20 each to the Shinbaro pharmacopuncture pharmacopunctureacupuncture, acupuncture, and usual care group, respectively. The 2 acupuncture groups will receive 2 sessionsweek of acupuncture alone or with pharmacopuncture for 4 weeks total 8 sessions, and the usual care group will receive conventional medication 2 timesday and 2 sessionsweek of physical therapy total 8 sessions. The initial acupuncture physician will administer acupuncture at 5 acupoints GB30, BL40, BL25, BL23, GB34 in the 2 acupuncture groups, and mark an additional acupoint. A second acupuncture physician will administer pharmacopuncture to the marked acupoint in the pharmacopuncture group, and acupuncture in the acupuncture group. Post-treatment evaluations will take place 5, 7, 9, and 12 weeks after randomization. 